Prenetics Global Future Growth
Future criteria checks 2/6
Prenetics Global is forecast to grow earnings and revenue by 58.9% and 69.6% per annum respectively while EPS is expected to grow by 66.9% per annum.
Key information
58.9%
Earnings growth rate
66.9%
EPS growth rate
| Healthcare earnings growth | 16.3% |
| Revenue growth rate | 69.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 90 | -10 | N/A | N/A | 1 |
| 12/31/2024 | 35 | -47 | N/A | N/A | 1 |
| 12/31/2023 | 22 | -54 | N/A | N/A | N/A |
| 9/30/2023 | 280 | -18 | N/A | N/A | N/A |
| 6/30/2023 | 279 | -23 | N/A | N/A | N/A |
| 3/31/2023 | 201 | -168 | N/A | N/A | N/A |
| 12/31/2022 | 276 | -190 | 8 | 15 | N/A |
| 9/30/2022 | 288 | -278 | N/A | N/A | N/A |
| 6/30/2022 | 283 | -343 | -27 | -19 | N/A |
| 3/31/2022 | 310 | -209 | N/A | N/A | N/A |
| 12/31/2021 | 276 | -174 | 2 | 13 | N/A |
| 9/30/2021 | 238 | -94 | 3 | 15 | N/A |
| 6/30/2021 | 190 | -4 | -15 | -6 | N/A |
| 3/31/2021 | 119 | 1 | -14 | -8 | N/A |
| 12/31/2020 | 65 | -2 | -6 | -3 | N/A |
| 12/31/2019 | 9 | -20 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PRE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PRE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PRE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PRE's revenue (69.6% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: PRE's revenue (69.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PRE's Return on Equity is forecast to be high in 3 years time